Tahoe Therapeutics (formerly Vevo Therapeutics) is a biotechnology company using its in vivo drug discovery platform and next generation AI models to uncover better drugs for more patients. The company’s Mosaic platform is the first to make in vivo data generation scalable, with single-cell precision, to capture in vivo context of disease at the first step of drug discovery and to better represent patient diversity in drug response over current in vitro assays. Tahoe is using Mosaic to build the world’s largest in vivo atlas of how drugs interact with patient cells and training AI models on its data to find novel targets and drugs undetectable by other technologies.
Located in South San Francisco, CA, Tahoe was founded by a team of inventors and thought leaders who have discovered drugs for “undruggable” targets and invented novel methods in genomics, computational biology, and chemistry. Learn more at www.tahoebio.ai.
Company Details
- Employees
- 25
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.tahoebio.ai/
Tahoe Therapeutics Questions
Tahoe Therapeutics's website is https://www.tahoebio.ai/
Tahoe Therapeutics's LinkedIn profile is https://www.linkedin.com/company/tahoe-therapeutics
Tahoe Therapeutics has
25 employees.
View email and phone details for 25
employees at Tahoe Therapeutics.
Tahoe Therapeutics's industry is
Biotechnology Research
Tahoe Therapeutics's top competitors are
Ultima Genomics,
Genentech,
Flagler Health,
Verge Genomics,
Parse Biosciences,
Orby Ai,
Arc Institute,
Chipstack,
Mana.bio,
Exai Bio.
Tahoe Therapeutics's categories are Biotechnology Research
Tahoe Therapeutics's founding year is 2022
